chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in arm, injection site muscle, loss of strength in forearm. Inability to use that hand for grasping, severe pain down entire arm. Confusion. Had tetanus shot from getting punctured by rusty old nail. Person giving vaccine said she wasn't very good giving shot in left arm because she's left handed very painful at right injection site that day then muscle loss and coordination in that arm and hand set in. Became severe so went to PCP who didn't think the shot could cause this but ordered EMG. Those results said it's outcome was abnormal and warranted further testing. So had the abnormal and warranted further testing. So had the MRI and ultrasound test. Have seen a orthopedic surgeon and appointment to see him again. As of today no one had an answer, muscle still wasting and cannot grip with that hand. This all started after (soon) this injection was given. Through this all there has been joint pain in my wrist and stiffness as well as my elbow.
Flare up of symptoms; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Flare up of symptoms) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    No Medical History information was reported.   In March 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In March 2022, the patient experienced CONDITION AGGRAVATED (Flare up of symptoms). At the time of the report, CONDITION AGGRAVATED (Flare up of symptoms) had not resolved.            It was unknown if patient was enrolled in a covid 19 vaccine trial. Concomitant drug not reported. No relevant medical history reported.
Redness, swelling, and tenderness on left arm near the vaccine site (but not where it was administered). Symptoms started around 12 hours and has persisted to now (3 days after vaccination).
This is a spontaneous report from a contactable consumer or other non hcp. A 57-year-old non pregnant female patient received bnt162b2 (COVID-19 VACCINE solution for injection) dose 1 via an unspecified route of administration, administered in left arm on 26Feb2021 at 10:30 (Batch/Lot Number: EN6198) as 1st dose, single for covid-19 immunization. The patient's medical history included Hyperthyroidism from an unknown date. The patient's concomitant medications were not reported. The patient had no known allergies. On 26Feb2021 at 14:00, 3 Hours 30 minutes after the vaccination the patient experienced Fatigue, Fever and Malaise. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. No treatment was received for the event. The outcome of the events was recovered on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.
Experienced nausea and vomited during post vaccination observation period. Monitored for another hour with improvement of symptoms. Pt did receive 2nd vaccine dose on 05/15/2021 without incident
Pt was administered ZOSTAVAX here at store on 6-7-10. He said around 6-10-10 he broke out in a rash that was extremely itchy, but did not consult us until today (6-23-10). He said it was a "painful itch." We referred him to doctor, he was given PREDNISONE and BENADRYL.
Information has been received from a licensed practical nurse concerning an 11 year old female child with no medical history or allergies who on unspecified dates was vaccinated with two doses of VARIVAX (Merck). There was no concomitant medication. On 10-AUG-2010 the patient experienced chicken pox, with more than 50 spots on her head, abdomen, back and legs. There were no laboratory studies performed. The patient sought unspecified medical attention. At the time of report, the patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Day 1:  Red, swollen, sore area (circle over 3" in diameter)around the injection point.  Day 2:  fatigue body achiness, headache, but no fever.  Day 4:  swelling and redness began to subside somewhat, leaving a large doughnut-shaped green bruise with a reddish interior...and a lot of itching. Day 5 (today):  still bruised and itchy.
chills; headache; muscle aches; intense fatigue; This is a spontaneous report received from a contactable reporter(s) (Physician).  An adult female patient (not pregnant) received BNT162b2 (BNT162B2), in Aug2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), 1 day after the suspect product(s) administration, outcome "recovered"; HEADACHE (non-serious), 1 day after the suspect product(s) administration, outcome "recovered"; MYALGIA (non-serious), 1 day after the suspect product(s) administration, outcome "recovered", described as "muscle aches"; FATIGUE (non-serious), 1 day after the suspect product(s) administration, outcome "recovered", described as "intense fatigue". Additional information: the patient reported experiencing 1 day of chills and 5 days of headache, muscle aches and intense fatigue beginning the day after receiving her first booster (3rd Pfizer vaccine shot) 8 months after completing her primary vaccination course of two doses of the Pfizer COVID-19 vaccine. On the sixth day after receiving her booster shot, the patient awoke feeling normal with all symptoms resolved. She had experienced similar symptoms 1 day after each of the two doses of Pfizer vaccine that lasted only for 1 day each during her primary vaccination sequence of dosing.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : PFIZER INC-202200820919 same product/ patient/event, different dose;PFIZER INC-202200813752 same product/ patient/event, different dose;
A report received from a health professional on 30Oct02, concerning approx 10 vaccinees who inadvertently received last years formulation of Fluvirin. From 28Oct02 to 30Oct02, 20-30 staff members were vaccinated with Fluvirin. After finishing the vaccination, a staff member noticed that one of the used vials was last years vaccine (2001-2002). The vial was discarded, thus the batch number is not available. There was insufficient information to determine the reporters causality assessment. Update 1 27Jan03: A report was received from a health care professional concerning a 29 year old female vaccinee who received expired influenza vaccine (brand unspecified) on an unspecified date. The vaccinee was subsequently revaccinated with this years influenza vaccination and experienced no adverse reaction. See Ref: PJP200200635, PJP20030049, PJP200300051, PJP200300052, PJP200300053, PJP200300054.
30 minutes after injection I started itching (ears, nose, face, scalp, lips, various other body parts)  Treatment: Benadryl 25mg, I?ve continued to take as needed for itching.
Patient in clinic for third COVID Vaccine.  Nurse adminstered Pfizer Vaccine instead of Moderna
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 04-MAR-2016, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 10-NOV-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
CHEST TIGHTNESS; NEED TO KEEP CLEARING HER THROAT; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 at 10:00 on left arm for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced chest tightness. On 11-MAR-2021, the subject experienced need to keep clearing her throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chest tightness and need to keep clearing her throat was not reported. This report was non-serious.
Had Pfizer COVID on 12-18-20, 1-7-21.  Have Pfizer COVID Booster on 9-29-21
After vaccine, appx 3 hrs, runny nose, difficulty breathing, at 4 hrs, nausea & vomiting lasting for appx 4 hrs. Chills, shaking for apprx 4 hrs. Total duration of symptoms appx 12 hrs. Next couple days, soreness from muscles aches & from vomiting.
Pt given VIS, no information given on pregnancy at time. Pt received vaccine and later told me that she was pregnant due in 8/08
Red rash near injection site, slightly raised; Red rash near injection site, slightly raised; Red rash near injection site, slightly raised; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non- pregnant female patient received bnt162b2 (BNT162B2, solution for injection, Lot number and expiry date was not reported), dose 1 via an unspecified route of administration, administered in arm Left on 19Jan2021 09:45 as single dose for covid-19 immunisation. Patient was not tested for COVID before vaccination. Patient was not tested for COVID post vaccination. Patient did not took any other vaccine in 4 weeks. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced Red rash near injection site, slightly raised. The outcome of the events was recovering. There was no treatment given to treat events.  Information on the lot/batch number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Feeling very week; body aches; pain all over her body; Fever; Headache; Vomits; Chills; A spontaneous report was received from a healthcare professional concerning a 51-year old, female patient who received Moderna's COVID-19 vaccine and experienced chills, fever, headache, body ache, pain all over, vomiting and feeling weak.    The patient's medical history included COVID-19. No relevant concomitant medications were reported.   On 02 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 02 Jan 2021, the patient experienced chills. On 03 Jan 2021, she began to experience chills, fever, headache, body aches, pain all over her body, and vomiting. On 04 Jan 2021, the patient reported feeling very weak, but better. No symptoms persisted at the time of report (06 Jan 2021). Treatment included paracetamol.   Action taken with mRNA-1273 in response to the events was not reported.   The events, chills, fever, headache, body ache, pain all over, vomiting and feeling weak, were considered recovered on 06 Jan 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Noted increase in arthritic stiffness and pain and new left hip/SI joint pain since the 2nd vaccine.
Peyronie's Disease; onset approximately one month after 2nd dose. no history of prior related symptoms. Echocardiogram showed thickening of walls and decreased ejection fraction after normal Echo in MAY 2020.
No adverse event; patients received Monovalent Booster instead of Bivalent booster of Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (patients received Monovalent Booster instead of Bivalent booster of Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053B22A) for COVID-19 immunisation.     No Medical History information was reported.    On 16-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (patients received Monovalent Booster instead of Bivalent booster of Moderna COVID-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (patients received Monovalent Booster instead of Bivalent booster of Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (patients received Monovalent Booster instead of Bivalent booster of Moderna COVID-19 vaccine).    No concomitant medications was reported. No treatment medications was reported.
Received flu shot at clinic on 10.23.13, no irritation noted Wed. or Thurs. Left upper arm has 4 cm area or erythema/warmth over injection site that began 10.25.13 sometime in the afternoon at school.
Burning sensation as shot was administered. Sensation traveled up the arm to the chest. Once it reached the chest, vision was compromised by spots and there was a tingling sensation throughout the whole body. Face swelling, entire body turning red. Severe nausea and lightheadedness. Time course was about 1 minute for everything. Treatment was going to be epi, but a Zyrtec pill was given instead as well as other nurses using ice packs to cool down body temperature.
No additional AE reported.; GARDASIL 9 has been administered since the excursion occurred.; This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies, reactions or concomitant medications was not provided.  On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9 SYRINGE (DEVICE)) for prophylaxis (lot number 1780878 had been verified to be a valid number; expiration date 02-DEC-2023, and upon internal validation established as the same date) (dose, vaccination scheme, frequency, route of administration, and anatomical site of injection were not reported). The administered dose of the vaccine was stored at a temperature of -0.5 degrees Celsius (C), for a time frame of 168 hours, as recorded by a digital data logger. There was no previous temperature excursion reported. There was no adverse effect reported.   This is a non-valid case due to the lack of patient identifiers.  Follow-up information has been received from a nurse on 01-DEC-2022.  The patient's demographics had been provided, a 20-years old male patient. His concurrent conditions included sinusitis and hypertension. The patient's pertinent medical history, drug allergies, reactions or concomitant medications was not provided.  On 24-OCT-2022, the patient was vaccinated with the third dose of an improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (conflicting information, also reported as quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine [GARDASIL]) injection, intramuscularly, on the right arm (dose, vaccination scheme and frequency were not provided) for prophylaxis (lot number 1780878 had been verified to be a valid number; expiration date 02-DEC-2023, and upon internal validation established as the same date). The reporter stated that the refrigerator for the vaccine went out of temperature range for too long and they did not realize until after the vaccine was given. The patient did not report any adverse effects. The rest of the vaccines had been properly dealt with.
patient blacked out for 10 seconds after vaccine administration. he waited 30 minutes so he can be monitored and was fine so he left the store.
This spontaneous report was received from a certified medical assistant and refers to an unspecified number of patients of unknown ages and genders. The patients' concurrent conditions and medical histories were not provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L016429, expiry date 09-AUG-2017 (dose and route were not reported). Concomitant therapies were not provided. According to the reporter, the vaccines were stored at a temperature of 34.5 degrees Fahrenheit for 72.3 hours. There was no previous temperature excursion reported. No symptoms were reported. No product quality complains (PQC) were involved. Additional information has been requested.
p/vax pt died from apparent SIDS on10/24/99;parents stated pt had no reaction from immunizations
dependent edema that started the day after #2 vaccine and has been intermittent ever since.
it hurt her arm; it was swollen for a while; Very dry mouth; nauseated; can't taste the food; really bad headache; really exhausted; diarrhea; everything hurts (neck, back, legs, knees and jaw bones) cramps in her legs; everything hurts (neck, back, legs, knees and jaw bones) cramps in her legs; brain fog (needs to double check everything she does); not feeling well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 2022 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization; Bnt162b2 (Dose: 2), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2022, outcome "unknown", described as "it hurt her arm"; PERIPHERAL SWELLING (non-serious) with onset 2022, outcome "unknown", described as "it was swollen for a while"; DRY MOUTH (non-serious) with onset 2022, outcome "unknown", described as "Very dry mouth"; NAUSEA (non-serious) with onset 2022, outcome "unknown", described as "nauseated"; TASTE DISORDER (non-serious) with onset 2022, outcome "unknown", described as "can't taste the food"; HEADACHE (non-serious) with onset 2022, outcome "unknown", described as "really bad headache"; FATIGUE (non-serious) with onset 2022, outcome "unknown", described as "really exhausted"; DIARRHOEA (non-serious) with onset 2022, outcome "unknown", described as "diarrhea"; PAIN (non-serious), MUSCLE SPASMS (non-serious) all with onset 2022, outcome "unknown" and all described as "everything hurts (neck, back, legs, knees and jaw bones) cramps in her legs"; FEELING ABNORMAL (non-serious) with onset 2022, outcome "unknown", described as "brain fog (needs to double check everything she does)"; MALAISE (non-serious) with onset 2022, outcome "unknown", described as "not feeling well".  Additional Information: Patient reported that she had her Pfizer Covid19 Booster shot at pharmacy 2 weeks ago, and it hurt her arm, it was swollen for a while, and right after the shot she had symptoms. She stated that up until now she was still not feeling well. She never had these problems with the first 2 shots of the Pfizer-BioNTech Covid19 Vaccine. She wanted to know what's wrong with her and when this will go away.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Difficulty breathing, difficulty talking (run out of breath), sadness, trouble concentration, loss of memory, loss of taste, chest pain all caused by Vaccine Interactions with medication called Klonopin for epilepsy
12/7 - Redness, swelling at injection site, hot to touch. Hives down arm on side of injection as well as on chest abdomen and R lower extremity. Pt also had diarrhea. Ice applied to site. Benadryl taken for 3 days. Benadryl cream applied to skin.
Headache began 3 days post immunization. Progressed to stiff neck, fever 100.5, and severe headache. To ER: Spinal tap neg. CT also neg. Sx resolving 07/29/2003. Using Tylenol
The morning after immunization, pt developed swelling/redness/warmth, reported itching from shoulder down to elbow.
4-17 Fever with flu for 24 hrs.,  5-12 Fever with flu for 24 hrs., 6-7 Fever with flu for 24 hrs.,  7-20 Fever with flu for 24 hrs. 7-30  burning and itching of lips, itching gradually spread to face, neck and chest. Per MD discontinued Celecoxib and Lisinopril. Itch continued to intensify and referred to dermatology. Biopsy taken on neck. Several topicals prescribed to affected areas. Diagnosed as seborrheic dermatitis. Some improvement with treatment but itch continues.  Late August noted lot of dry secretions in upper nasal passages as well as some dried blood.In last month nasal passages occluding requiring ENT intervention.   Superficial blood clot left lleg.
Fever, chills, headache, muscle aches, tiredness, elevated heart rate (80-90 bpm)
May 4, 2021 I had  a  SARS-COV-2  Antibody (IgG), Spike, Semi-Quantitative blood test done.  The result was Nonreactive .56..  I was told that this indicates I have no antibodies/immunity  from my vaccines on 2/4/2021 &  2/27/2021.  I need some guidance on how to handle this situation.  Do I get another vaccination?   My doctor does not know how I should proceed.
two days later, i started to get shortness of breath, my lungs felt like i was waterlogged, i had body aches and chills, and got weak felt like passing out, then i got shingles ....still have nerve pain to this day from it...rashes gone but nerve pain there...felt like death